Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.
Clinical trial NCT03988023 · TERMINATED
Trial details
- NCT number
- NCT03988023
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2021-07-13
- Enrollment
- 1043
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.